We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




RF Destroys Tumors, Keeps Kidney Intact

By HospiMedica staff writers
Posted on 08 Apr 2003
A study has shown that radiofrequency (RF) ablation can destroy small renal masses while maintaining normal kidney function. More...
The study was published in the April 2003 issue of the American Journal of Roentgenology.

Many renal masses are detected while a patient is undergoing an imaging examination for a different reason. More than 90% of renal masses are cancerous. Because of this, most patients automatically undergo a partial or total nephrectomy, which removes part or all of the kidney. Complications occur in 12-30% of cases and include hemorrhage and urine leakage. Complications and the fact that about 10% of renal masses are benign reinforce the need for less-radical treatment.

In the study, doctors used RF ablation to treat 24 tumors, all less than 5 cm, in 20 patients. The treatment takes only 10-25 minutes. Follow-up ranged from 2-39 months, with excellent technical success and no local recurrence of disease. Only minor complications occurred. Most patients, although fit for discharge the same day, were kept overnight as a precaution.

"Our study suggests that radiofrequency ablation may be the best way to manage many small renal masses. This treatment is part of a growing trend toward minimally invasive, image-guided therapies designed to reduce the morbidity of treatment and the length of hospital stays,” said David J. Breen, M.D., of Southampton University Hospitals (UK). The study was conducted by Dr. Breen and colleagues.




Related Links:
Southampton U. Hospitals

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.